International Psoriasis Council

Advancing Knowledge. Improving Care.

Alexander

Navarini

,

MD, PhD

Chair of Dermatology
University Hospital of Basel
Basel
,
Switzerland
Councilor Since: September 1, 2019
IPC Councilor
Dr. Alexander Navarini has been chairman of the Department of Dermatology at the University Hospital of Basel since 2018. Previously, he was a professor of immunodermatology, deputy head of the outpatient clinic, and head of the patch testing laboratory at the University of Zurich. After medical studies in Basel and Paris, he was awarded an MD PhD at the University of Zurich. His research focuses on visual quantification and detection of skin diseases, immunology, next-generation genetics, and gene hunting. He has published over 330 peer-reviewed articles and several book chapters. He is currently the Principal Investigator of the International Rare and Severe Psoriasis Network (ERASPEN) for pustular psoriasis and the Swiss psoriasis registry.
Last Updated:
04/24/2025

IPC Committees / Groups

Digital Health Working Group, Telemedicine Working Group

Languages Spoken

English, German

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026